121 related articles for article (PubMed ID: 884690)
1. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.
Mellett LB
Cancer Treat Rep; 1977 Jul; 61(4):527-31. PubMed ID: 884690
[TBL] [Abstract][Full Text] [Related]
2. Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
Cancer Res; 1991 Apr; 51(8):1979-83. PubMed ID: 2009516
[TBL] [Abstract][Full Text] [Related]
3. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Holm B; Sehested M; Jensen PB
Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery to brain tumours: challenges and progress.
Ningaraj NS
Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
[TBL] [Abstract][Full Text] [Related]
5. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
[TBL] [Abstract][Full Text] [Related]
6. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
7. [The blood-brain barrier: implications for chemotherapy in brain tumors].
Boaziz C; Breau JL; Morère JF; Israël L
Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
9. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
11. [Effect of dioxadet on tumors transplanted to the brain].
Stukov AN; Korsakov MV; Khrapova TN; Kil'maeva NE; Kraĭz BO
Vopr Onkol; 1986; 32(10):64-7. PubMed ID: 3776129
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to the brain using polymers.
Domb A; Maniar M; Bogdansky S; Chasin M
Crit Rev Ther Drug Carrier Syst; 1991; 8(1):1-17. PubMed ID: 1868550
[TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study.
Ginsberg S; Kirshner J; Reich S; Panasci L; Finkelstein T; Fandrich S; Fitzpatrick A; Shechtman L; Comis R
Cancer Treat Rep; 1981; 65(5-6):477-83. PubMed ID: 6165472
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier].
Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M
Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic bases of chemotherapy of brain tumors in children].
Vassal G
Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier and treatment of central nervous system tumors.
Wiranowska M
J Fla Med Assoc; 1992 Oct; 79(10):707-10. PubMed ID: 1460453
[TBL] [Abstract][Full Text] [Related]
17. Issues in developing drugs for primary brain tumors: barriers and toxicities.
Raizer J
Toxicol Pathol; 2011 Jan; 39(1):152-7. PubMed ID: 21147933
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Finch RA; Shyam K; Penketh PG; Sartorelli AC
Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
[TBL] [Abstract][Full Text] [Related]
20. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
